Myocardial Injury in COVID-19—Can We Successfully Target Inflammation? | JAMA Cardiology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
Comment & Response
July 15, 2020

Myocardial Injury in COVID-19—Can We Successfully Target Inflammation?

Author Affiliations
  • 1General Hospital of Athens “G.Gennimatas,” Athens, Greece
  • 2Department of Cardiovascular Medicine, Humanitas Clinical and Research Hospital, Milan, Italy
  • 3Attikon Hospital, 2nd Department of Cardiology, National and Kapodistian University of Athens Medical School, Athens, Greece
JAMA Cardiol. 2020;5(9):1069-1070. doi:10.1001/jamacardio.2020.2569
×